Ipafricept Uses, Dosage, Side Effects and more

Ipafricept is under investigation in clinical trial NCT01608867 (A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors).

Trade Name Ipafricept
Generic Ipafricept
Ipafricept Other Names Ipafricept, OMP-54F28
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share